Lupin Pursues India Approval For Lucentis Biosimilar, COVID-19 Opportunities

Favors Voluntary Licensing

 
• By Vibha Ravi
  
Lab Instruments
Lupin Seeks Approval For Lucentis Biosimilar In India As It Expands Product Pipeline • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip